Trial Profile
NovoRapid in pregnancy - safety and efficacy versus human insulin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2012
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Pregnancy; Pregnancy complications; Preterm birth; Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Novo Nordisk
- 01 Mar 2010 Exploratory analysis comparing patients randomised pre-conception and patient randomised in early pregnancy published in Diabetes Care.
- 12 May 2009 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
- 01 Mar 2009 Cost-effectiveness analysis published in Current Medical Research and Opinion.